Modern Approaches to the Study of Ethical and Deontological Aspects in Pharmaceutical Counseling of Hiv-Infected Patients

Pharmaceutical counseling for HIV infection is responsible provision of information in order to achieve certain results to improve or preserve the patient's quality of life. In the modern world, the problem of the spread of HIV infection remains relevant. The relevance of the study is determined by the need to improve the ethical and deontological aspects of pharmaceutical counseling for HIV-infected patients. Specialized pharmaceutical care for HIV-infected patients includes information and counseling aimed at improving treatment outcomes and is achieved by providing the patient with up-to-date, complete and reliable scientific information based on the requirements of pharmaceutical ethics and deontology. Pharmaceutical counseling for patients with HIV infection is a special field of professional activity that requires a deep understanding of ethical standards and deontological principles, and the formation of a competent approach to their counseling is of particular importance. Aim-study of modern approaches to the organization of pharmaceutical counseling for HIV-infected patients, taking into account ethical standards and principles of pharmaceutical deontology Materials and methods. The following research methods were used: content analysis, sociological, statistical, logical, modeling and forecasting, observation, questionnaires and scientific approaches: structural and functional, systemic, regional, etc. Statistical data processing was carried out in the Statistica 10 program. Results. When providing specialized pharmaceutical care to HIV-infected patients, a pharmaceutical worker should be especially attentive to their emotional state. HIV infection is often accompanied by fear, anxiety, and depression. A pharmaceutical worker can help a patient cope with these emotions by providing them with information about the disease, treatment methods, and possible side effects. However, it is important not to violate the boundaries of the patient's personal space and not cause negative emotions in him. When working with HIV-infected patients, a pharmaceutical worker must take into account the specifics of their condition and needs based on the requirements of pharmaceutical ethics and pharmaceutical deontology. The results of the study showed an insufficient level of patient awareness in a number of important areas, which requires improvement of the pharmaceutical counseling system. Conclusion. The study of ethical and deontological aspects of pharmaceutical counseling for HIV-infected patients is an important area that helps pharmaceutical workers improve the quality of their work and ensure more effective interaction in pharmaceutical counseling with HIV-infected patients.